Asymmetric Synthesis of the HIV Protease Inhibitor TMC-126, a PMX Antimalarial Protease Inhibitor, and a Putative COVID-19 Inhibitor Using a Highly Stereoselective Glycolate Aldol Addition Reaction Pathway
ACS Omega · 12.05.2026 · 11 (18) · 27331-27341
DOI: 10.1021/acsomega.6c01499 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 01.05.2026. Verfasst von Kweku Amaning Affram und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
An asymmetric glycolate aldol addition pathway was developed for the synthetic preparation of a series of protease inhibitors based on the hydroxyethylamine structural motif. A single glycolate aldol adduct derived from a highly diastereoselective (≥95:5 d.r.) asymmetric aldol reaction served as the starting point for the synthesis of the inhibitors. The starting material is easily prepared and purified via recrystallization on multigram scales. This work describes the synthesis of the HIV protease inhibitor TMC-126, the Plasmepsin X (PMX) inhibitor 49c for the treatment of malaria, and a computationally derived inhibitor for the 3CLpro of the SARS-CoV-2 from a single common synthetic intermediate.
Autor:innen und Institutionen
- Department of Chemistry, Illinois State University, Normal, Illinois 61790-4160, United States.
ORCID-Profile: Shawn R Hitchcock
Zitieren
APA
Affram, K. A., Carter, A., Breede, A., Kimsey, A., Hemeson, G., Semakieh, B., Martinez, M., Ayim, E., Odeh, J., & Hitchcock, S. R. (2026). Asymmetric Synthesis of the HIV Protease Inhibitor TMC-126, a PMX Antimalarial Protease Inhibitor, and a Putative COVID-19 Inhibitor Using a Highly Stereoselective Glycolate Aldol Addition Reaction Pathway. ACS Omega, 11(18), 27331-27341. https://doi.org/10.1021/acsomega.6c01499
Vancouver
Affram KA, Carter A, Breede A, Kimsey A, Hemeson G, Semakieh B, et al. Asymmetric Synthesis of the HIV Protease Inhibitor TMC-126, a PMX Antimalarial Protease Inhibitor, and a Putative COVID-19 Inhibitor Using a Highly Stereoselective Glycolate Aldol Addition Reaction Pathway. ACS Omega. 2026;11(18):27331-27341. doi:10.1021/acsomega.6c01499
BibTeX
@article{Affram2026,
author = {Affram, Kweku Amaning and Carter, Austin and Breede, April and Kimsey, Alexandria and Hemeson, Godson and Semakieh, Bader and Martinez, Moses and Ayim, Emmanuel and Odeh, Joy and Hitchcock, Shawn R},
title = {Asymmetric Synthesis of the HIV Protease Inhibitor TMC-126, a PMX Antimalarial Protease Inhibitor, and a Putative COVID-19 Inhibitor Using a Highly Stereoselective Glycolate Aldol Addition Reaction Pathway},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {18},
pages = {27331--27341},
doi = {10.1021/acsomega.6c01499}
}
EUVIMED